JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 3610
  • +270+8.08%
20min DelayMarket Closed Dec 27 15:30 JST
181.08BMarket Cap21.80P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees839
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Thomas Eastling
  • Director
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
Twenty-four seven
7074
290 +33.64%
Alpico Holdings
297A
321 +33.20%
Branding Technology
7067
1338 +28.90%
Estore
4304
1504 +24.92%
Axel Mark
3624
172 +22.86%

See the daily top gainer.